Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

• Status: Completed
• Trial end date: 2004-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy of atorvastatin in lowering cholesterol on patients from Thailand with high cholesterol.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Dyslipidemic patients who were eligible for lipid lowering therapy

• Willingness to follow study diet for 1 month prior to screening and for the duration of the study

Exclusion Criteria:

• Use of other lipid lowering agents (6-week washout period)

• Uncontrolled high blood pressure

• Impaired liver function